High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells
Title: | High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells |
---|---|
Authors: | Chansavath Phetsouphanh, Weng Hua Khoo, Katherine Jackson, Vera Klemm, Annett Howe, Anupriya Aggarwal, Anouschka Akerman, Vanessa Milogiannakis, Alberto Ospina Stella, Romain Rouet, Peter Schofield, Megan L. Faulks, Hannah Law, Thidarat Danwilai, Mitchell Starr, C. Mee Ling Munier, Daniel Christ, Mandeep Singh, Peter I. Croucher, Fabienne Brilot-Turville, Stuart Turville, Tri Giang Phan, Gregory J. Dore, David Darley, Philip Cunningham, Gail V. Matthews, Anthony D. Kelleher, John J. Zaunders |
Source: | Frontiers in Immunology, Vol 13 (2022) |
Publisher Information: | Frontiers Media S.A., 2022. |
Publication Year: | 2022 |
Collection: | LCC:Immunologic diseases. Allergy |
Subject Terms: | SARS-CoV-2, neutralizing antibodies, CD4 T cells, CD4 function, proliferation, Immunologic diseases. Allergy, RC581-607 |
More Details: | BackgroundLong-term immunity to SARS-CoV-2 infection, including neutralizing antibodies and T cell-mediated immunity, is required in a very large majority of the population in order to reduce ongoing disease burden.MethodsWe have investigated the association between memory CD4 and CD8 T cells and levels of neutralizing antibodies in convalescent COVID-19 subjects.FindingsHigher titres of convalescent neutralizing antibodies were associated with significantly higher levels of RBD-specific CD4 T cells, including specific memory cells that proliferated vigorously in vitro. Conversely, up to half of convalescent individuals had low neutralizing antibody titres together with a lack of receptor binding domain (RBD)-specific memory CD4 T cells. These low antibody subjects had other, non-RBD, spike-specific CD4 T cells, but with more of an inhibitory Foxp3+ and CTLA-4+ cell phenotype, in contrast to the effector T-bet+, cytotoxic granzymes+ and perforin+ cells seen in RBD-specific memory CD4 T cells from high antibody subjects. Single cell transcriptomics of antigen-specific CD4+ T cells from high antibody subjects similarly revealed heterogenous RBD-specific CD4+ T cells that comprised central memory, transitional memory and Tregs, as well as cytotoxic clusters containing diverse TCR repertoires, in individuals with high antibody levels. However, vaccination of low antibody convalescent individuals led to a slight but significant improvement in RBD-specific memory CD4 T cells and increased neutralizing antibody titres.InterpretationOur results suggest that targeting CD4 T cell epitopes proximal to and within the RBD-region should be prioritized in booster vaccines. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 1664-3224 |
Relation: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1032911/full; https://doaj.org/toc/1664-3224 |
DOI: | 10.3389/fimmu.2022.1032911 |
Access URL: | https://doaj.org/article/54f0e1950fa84edf8548d013da07f7a4 |
Accession Number: | edsdoj.54f0e1950fa84edf8548d013da07f7a4 |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16643224&ISBN=&volume=13&issue=&date=20221201&spage=&pages=&title=Frontiers in Immunology&atitle=High%20titre%20neutralizing%20antibodies%20in%20response%20to%20SARS%E2%80%93CoV%E2%80%932%20infection%20require%20RBD%E2%80%93specific%20CD4%20T%20cells%20that%20include%20proliferative%20memory%20cells&aulast=Chansavath%20Phetsouphanh&id=DOI:10.3389/fimmu.2022.1032911 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/54f0e1950fa84edf8548d013da07f7a4 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.54f0e1950fa84edf8548d013da07f7a4 RelevancyScore: 953 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 953.493530273438 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Chansavath+Phetsouphanh%22">Chansavath Phetsouphanh</searchLink><br /><searchLink fieldCode="AR" term="%22Weng+Hua+Khoo%22">Weng Hua Khoo</searchLink><br /><searchLink fieldCode="AR" term="%22Katherine+Jackson%22">Katherine Jackson</searchLink><br /><searchLink fieldCode="AR" term="%22Vera+Klemm%22">Vera Klemm</searchLink><br /><searchLink fieldCode="AR" term="%22Annett+Howe%22">Annett Howe</searchLink><br /><searchLink fieldCode="AR" term="%22Anupriya+Aggarwal%22">Anupriya Aggarwal</searchLink><br /><searchLink fieldCode="AR" term="%22Anouschka+Akerman%22">Anouschka Akerman</searchLink><br /><searchLink fieldCode="AR" term="%22Vanessa+Milogiannakis%22">Vanessa Milogiannakis</searchLink><br /><searchLink fieldCode="AR" term="%22Alberto+Ospina+Stella%22">Alberto Ospina Stella</searchLink><br /><searchLink fieldCode="AR" term="%22Romain+Rouet%22">Romain Rouet</searchLink><br /><searchLink fieldCode="AR" term="%22Peter+Schofield%22">Peter Schofield</searchLink><br /><searchLink fieldCode="AR" term="%22Megan+L%2E+Faulks%22">Megan L. Faulks</searchLink><br /><searchLink fieldCode="AR" term="%22Hannah+Law%22">Hannah Law</searchLink><br /><searchLink fieldCode="AR" term="%22Thidarat+Danwilai%22">Thidarat Danwilai</searchLink><br /><searchLink fieldCode="AR" term="%22Mitchell+Starr%22">Mitchell Starr</searchLink><br /><searchLink fieldCode="AR" term="%22C%2E+Mee+Ling+Munier%22">C. Mee Ling Munier</searchLink><br /><searchLink fieldCode="AR" term="%22Daniel+Christ%22">Daniel Christ</searchLink><br /><searchLink fieldCode="AR" term="%22Mandeep+Singh%22">Mandeep Singh</searchLink><br /><searchLink fieldCode="AR" term="%22Peter+I%2E+Croucher%22">Peter I. Croucher</searchLink><br /><searchLink fieldCode="AR" term="%22Fabienne+Brilot-Turville%22">Fabienne Brilot-Turville</searchLink><br /><searchLink fieldCode="AR" term="%22Stuart+Turville%22">Stuart Turville</searchLink><br /><searchLink fieldCode="AR" term="%22Tri+Giang+Phan%22">Tri Giang Phan</searchLink><br /><searchLink fieldCode="AR" term="%22Gregory+J%2E+Dore%22">Gregory J. Dore</searchLink><br /><searchLink fieldCode="AR" term="%22David+Darley%22">David Darley</searchLink><br /><searchLink fieldCode="AR" term="%22Philip+Cunningham%22">Philip Cunningham</searchLink><br /><searchLink fieldCode="AR" term="%22Gail+V%2E+Matthews%22">Gail V. Matthews</searchLink><br /><searchLink fieldCode="AR" term="%22Anthony+D%2E+Kelleher%22">Anthony D. Kelleher</searchLink><br /><searchLink fieldCode="AR" term="%22John+J%2E+Zaunders%22">John J. Zaunders</searchLink> – Name: TitleSource Label: Source Group: Src Data: Frontiers in Immunology, Vol 13 (2022) – Name: Publisher Label: Publisher Information Group: PubInfo Data: Frontiers Media S.A., 2022. – Name: DatePubCY Label: Publication Year Group: Date Data: 2022 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Immunologic diseases. Allergy – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22SARS-CoV-2%22">SARS-CoV-2</searchLink><br /><searchLink fieldCode="DE" term="%22neutralizing+antibodies%22">neutralizing antibodies</searchLink><br /><searchLink fieldCode="DE" term="%22CD4+T+cells%22">CD4 T cells</searchLink><br /><searchLink fieldCode="DE" term="%22CD4+function%22">CD4 function</searchLink><br /><searchLink fieldCode="DE" term="%22proliferation%22">proliferation</searchLink><br /><searchLink fieldCode="DE" term="%22Immunologic+diseases%2E+Allergy%22">Immunologic diseases. Allergy</searchLink><br /><searchLink fieldCode="DE" term="%22RC581-607%22">RC581-607</searchLink> – Name: Abstract Label: Description Group: Ab Data: BackgroundLong-term immunity to SARS-CoV-2 infection, including neutralizing antibodies and T cell-mediated immunity, is required in a very large majority of the population in order to reduce ongoing disease burden.MethodsWe have investigated the association between memory CD4 and CD8 T cells and levels of neutralizing antibodies in convalescent COVID-19 subjects.FindingsHigher titres of convalescent neutralizing antibodies were associated with significantly higher levels of RBD-specific CD4 T cells, including specific memory cells that proliferated vigorously in vitro. Conversely, up to half of convalescent individuals had low neutralizing antibody titres together with a lack of receptor binding domain (RBD)-specific memory CD4 T cells. These low antibody subjects had other, non-RBD, spike-specific CD4 T cells, but with more of an inhibitory Foxp3+ and CTLA-4+ cell phenotype, in contrast to the effector T-bet+, cytotoxic granzymes+ and perforin+ cells seen in RBD-specific memory CD4 T cells from high antibody subjects. Single cell transcriptomics of antigen-specific CD4+ T cells from high antibody subjects similarly revealed heterogenous RBD-specific CD4+ T cells that comprised central memory, transitional memory and Tregs, as well as cytotoxic clusters containing diverse TCR repertoires, in individuals with high antibody levels. However, vaccination of low antibody convalescent individuals led to a slight but significant improvement in RBD-specific memory CD4 T cells and increased neutralizing antibody titres.InterpretationOur results suggest that targeting CD4 T cell epitopes proximal to and within the RBD-region should be prioritized in booster vaccines. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 1664-3224 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://www.frontiersin.org/articles/10.3389/fimmu.2022.1032911/full; https://doaj.org/toc/1664-3224 – Name: DOI Label: DOI Group: ID Data: 10.3389/fimmu.2022.1032911 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/54f0e1950fa84edf8548d013da07f7a4" linkWindow="_blank">https://doaj.org/article/54f0e1950fa84edf8548d013da07f7a4</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.54f0e1950fa84edf8548d013da07f7a4 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.54f0e1950fa84edf8548d013da07f7a4 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.3389/fimmu.2022.1032911 Languages: – Text: English Subjects: – SubjectFull: SARS-CoV-2 Type: general – SubjectFull: neutralizing antibodies Type: general – SubjectFull: CD4 T cells Type: general – SubjectFull: CD4 function Type: general – SubjectFull: proliferation Type: general – SubjectFull: Immunologic diseases. Allergy Type: general – SubjectFull: RC581-607 Type: general Titles: – TitleFull: High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chansavath Phetsouphanh – PersonEntity: Name: NameFull: Weng Hua Khoo – PersonEntity: Name: NameFull: Katherine Jackson – PersonEntity: Name: NameFull: Vera Klemm – PersonEntity: Name: NameFull: Annett Howe – PersonEntity: Name: NameFull: Anupriya Aggarwal – PersonEntity: Name: NameFull: Anouschka Akerman – PersonEntity: Name: NameFull: Vanessa Milogiannakis – PersonEntity: Name: NameFull: Alberto Ospina Stella – PersonEntity: Name: NameFull: Romain Rouet – PersonEntity: Name: NameFull: Peter Schofield – PersonEntity: Name: NameFull: Megan L. Faulks – PersonEntity: Name: NameFull: Hannah Law – PersonEntity: Name: NameFull: Thidarat Danwilai – PersonEntity: Name: NameFull: Mitchell Starr – PersonEntity: Name: NameFull: C. Mee Ling Munier – PersonEntity: Name: NameFull: Daniel Christ – PersonEntity: Name: NameFull: Mandeep Singh – PersonEntity: Name: NameFull: Peter I. Croucher – PersonEntity: Name: NameFull: Fabienne Brilot-Turville – PersonEntity: Name: NameFull: Stuart Turville – PersonEntity: Name: NameFull: Tri Giang Phan – PersonEntity: Name: NameFull: Gregory J. Dore – PersonEntity: Name: NameFull: David Darley – PersonEntity: Name: NameFull: Philip Cunningham – PersonEntity: Name: NameFull: Gail V. Matthews – PersonEntity: Name: NameFull: Anthony D. Kelleher – PersonEntity: Name: NameFull: John J. Zaunders IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 16643224 Numbering: – Type: volume Value: 13 Titles: – TitleFull: Frontiers in Immunology Type: main |
ResultId | 1 |